FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from BPC ARG Double Strength LVLUP Health FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News